Sunesis Pharmaceuticals (SNSS) Reports Strong Q1 Results
Tweet
Share
E-mailGet Alerts SNSS Hot Sheet
Price: $5.32 --0%
Financial Fact:
General and administrative: 4M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
General and administrative: 4M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) reported Q1 EPS of $0.04, $0.18 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $4 million, versus $13 thousand reported last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- Deere & Co. (DE) Tops Q3 EPS by 41c, raises guidance
- Wolfspeed (WOLF) Misses Q4 EPS by 174c; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
